HLA-E and female reproductive organ cancer: Furthermore, in gynecologic cancers, high HLA-E expression in patients abrogated the survival benefit of high levels of cytotoxic tumor-infiltrating lymphocytes, suggesting that tumor HLA-E expression is a relevant factor when considering ICB or adoptive cell therapies for patients (107).